Dermatologists Raj Chovatiya, MD, PhD, and David Rosmarin, MD, discuss new research outcomes for the topical JAK inhibitor live from the Revolutionizing Atopic Dermatiti 2023 Annual Meeting in Washington, DC.
Back
The Latest Data for Ruxolitinib Cream in Vitiligo: Finding Context from the Outcomes
Dermatologists Raj Chovatiya, MD, PhD, and David Rosmarin, MD, discuss new research outcomes for the topical JAK inhibitor live from the Revolutionizing Atopic Dermatiti 2023 Annual Meeting in Washington, DC.
The Latest Data for Ruxolitinib Cream in Vitiligo: Finding Context from the Outcomes
Episodes
All
All
Advertisement
Advertisement
Trending on HCPLive
1
VESALIUS-CV: Evolocumab Prevents Cardiovascular Disease in High-Risk Diabetes
2
Does Artificial Intelligence Worsen Health Care Disparities?
3
Adverse Pregnancy Outcomes as a Predictor of Cardiovascular Disease Mortality
4
New Liver Cancer BEACON-HCC Framework Shows 96.6% Concordance in Pilot
5